What do the Google Patents claims say about vinblastine/vindoline biosynthesis?
Google Patents search results and the underlying US application text typically show that “vinblastine” claims are tied to one or more of the following elements: (1) engineered or controlled production of key precursors from plants or cells (often including vindoline), (2) steps that enable conversion/assembly into vinblastine, and/or (3) specific biosynthetic pathways, enzymes, and reaction conditions used to generate vinblastine or its immediate intermediates.
To answer precisely for your specific US application, I need the exact patent/application number or link (Google Patents uses different documents for different claim sets). With that, I can quote which claim phrases explicitly cover “biosynthesis” (for example, whether they claim “biosynthetic production,” “cell culture production,” “recombinant expression,” “pathway enzymes,” “vindoline formation,” or “vinblastine biosynthetic pathway”).
Which US patent application is being searched (and where does “vindoline” appear)?
“Vinblastine” and “vindoline” show up in claims in multiple contexts, but the meaning changes depending on how “vindoline” is used:
- If claims say production includes “vindoline” as an intermediate, that usually indicates the application is focused on building vinblastine by first generating vindoline (often in a cellular or engineered system) and then performing coupling/conversion steps.
- If claims mention vindoline only as a reference compound, that may indicate a narrower focus (for example, extraction/isolation or downstream formulation) rather than biosynthetic pathway engineering.
If you share the specific US application link or number, I can map claim language to which of these contexts it fits.
How to quickly verify “biosynthesis” in the claims on Google Patents
When you open the Google Patents page for the US application, use the claim text to look for keywords and claim structures that usually indicate biosynthesis rather than chemical synthesis or extraction, such as:
- “culturing” / “cell culture” / “plant cell” / “tissue”
- “recombinant” / “expressing” / “gene” / “polynucleotide” / “vector”
- “enzyme” / “enzyme activity” / “catalyze”
- “biosynthetic pathway” / “biosynthesized” / “biological conversion”
- “precursor” / “intermediate” (especially “vindoline”)
- “transforming” / “converting” one intermediate into another (toward vinblastine)
Send me the application number and I’ll tell you exactly which claims include (or exclude) those biosynthesis indicators.
Is this about patenting engineered pathways, or about producing vindoline/vinblastine in cells?
US vinblastine/vindoline biosynthesis filings often fall into two broad claim styles:
- Platform claims: engineered cells/plants and expression of pathway components that generate vindoline (and then vinblastine).
- Process claims: specific multi-step biological conversions and conditions that yield vinblastine, where vindoline is part of the defined intermediate sequence.
Your question asks specifically about “US patent application claims biosynthesis,” so the main thing to confirm is whether the claims are limited to (a) biosynthetic manufacturing using biological systems, or (b) non-biological synthesis where vindoline is merely an intermediate.
Where DrugPatentWatch.com can help (patent status and family)
If you’re trying to determine which application in the vinblastine/vindoline area is the one you care about, DrugPatentWatch.com can help identify relevant patent families and status so you can match the correct Google Patents document to the right claims set. You can search DrugPatentWatch for vinblastine and then click through to associated patents.
Source: https://www.drugpatentwatch.com/
What I need from you to give a claim-accurate answer
Please paste one of the following:
- the Google Patents link you’re looking at, or
- the US publication/application number (example format: US 20xx/xxxxxxx A1), or
- the assignee/company name plus the approximate publication year.
Then I’ll extract exactly which claim clauses in that document cover biosynthesis of vinblastine and vindoline (and how vindoline is treated in the pathway).
Sources
- DrugPatentWatch.com